Please Wait...

Biomarker Analysis

The use of biochemical markers as surrogate endpoints for measuring the effects of investigational compounds and monitoring disease progression has increased significantly over the last decade.

Bioclinica Lab has extensive experience with efficacy biomarkers, predictive biomarkers, and safety biomarkers. We offer more than 70 biochemical assays performed with manual and/or automated methods and determine the most suitable method for each biomarker according to performance and test kits. Our facilities are equipped with state of the art robotics and a dedicated laboratory space for performing radioactive assays. Using Multiplex technology, we offer our clients the ability to monitor several biomarkers in parallel.

Our biomarker assays include:
ELISA
Radioimmunoassays (IRMA, RIA)
ECLIA
CLIA
Colorimetric
Immunoturbidimetric
Multiplex (MagPix)
Our comprehensive biomarker panel
spans many therapeutic areas including:
Bone and Cartilage diseases
Oncology
Cardiovascular disease
CNS diseases (Alzheimer's)
Infectious diseases
Inflammatory and Immunological diseases
Metabolic diseases (Diabetes)

All Bioclinica Lab assays are validated and qualified in-house according to a rigorous evaluation process and current international guidelines. We can also perform assay validation of customer-selected biomarkers or adapt assays to special biological matrices (e.g. synovial fluid or BALF).

Assay Validation

Bioclinica Lab validates each kit/method used for biomarker detection in a clinical study. Using assay validation, we objectively establish the reliability of a particular analytical method and ensure the accuracy and reliability of results.

A validation report summarizes the results of a test performance at Bioclinica Lab compared to manufacturer's data.

  • assay procedures
  • intra- and inter- assay variations, recovery, linearity and limits of detection
  • biomarker stability in a specific matrix for storage conditions and freeze-thaw cycles
  • expected values for population type (if data are available)

 

Prior to validation, we recommend a feasibility study to our clients for evaluating the potential of a method in a regulatory compliant environment. Bioclinica Lab will objectively qualify biomarker performance using a series of tests including dosage linearity and selectivity for a specific biomarker in a chosen matrix. At the end of a feasibility study, Bioclinica Lab will determine confidence in the chosen method and suitability for use in clinical trials.

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

On the hunt for agile IRT? Ask these 5 Qs to see if it's the real thing. DISCLOSURE: We happen to have such an offe… https://t.co/S6507WxBC8
bioclinica (Yesterday)
Be among the 1st to hear findings presented in 6 scientific posters in which experts @bioclinica in #Alzheimers… https://t.co/4mBEtFiX0a
bioclinica (3 days ago)
Still using manual methods for trial budget management and forecasting ? A Bioclinica whitepaper shows how purpose-… https://t.co/WlrHLk9B0z
bioclinica (4 days ago)
Swing by @Bioclinica to discuss global site network partnering opportunities during @MySCRS Asia-Pac Site Solutions… https://t.co/m8GHxSmPMY
bioclinica (5 days ago)
Hello from Clinical Operations in Oncology Trials East Coast where Bioclinica is exhibiting & presenting a case stu… https://t.co/oTKJAVddH4
bioclinica (2 weeks ago)
Challenge overcome! Course-correct a clinical trial & collect 400 time points from 40 sites across the US & EU -- a… https://t.co/n3TLrjW3xi
bioclinica (2 weeks ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen